多静脉多球囊冠状静脉乙醇消融治疗结构性心脏病难治性室速
该研究对44例消融难治性室速的结构性心脏病患者行多球囊多静脉冠状静脉乙醇消融,中位乙醇量8.75 mL,随访1年室速复发7例,成功率84.1%,表明该技术可在广泛左室区域有效消融基质。
要点
- 多球囊多静脉冠状静脉乙醇消融可有效消融结构性心脏病难治性室速的基质。
- 该技术适用于广泛左室区域,包括心间静脉、对角、间隔、侧壁、后侧壁及心中静脉。
- 1年随访成功率84.1%,中位随访314天,复发7例。
核心结论
- 多球囊多静脉冠状静脉乙醇消融可为结构性心脏病消融难治性室速患者提供有效的基质消融,覆盖广泛左室区域。
研究设计与样本
- 连续纳入44例消融难治性室速患者,其中缺血性21例、结节病3例、恰加斯病2例、特发性18例,行冠状静脉乙醇消融。
主要发现
- 中位乙醇量为8.75 mL(四分位距4.5-13 mL),14例靶向多支静脉。
- 消融后静脉及心外膜标测显示室速基质异常电图消除,心内超声显示靶区域壁内回声增强。
- 随访中位314天(四分位距198-453天)时,7例室速复发,成功率84.1%。
关键数值与推荐
- 靶静脉通过标测心外膜侧内膜瘢痕(双极电压<1.5 mV)对应的冠状静脉选择,使用静脉造影和2F八极导管或导丝单极信号记录。
- 15例行心外膜标测,22例通过晚期钆增强心脏磁共振成像评估消融瘢痕及其演变。
- 采用双球囊技术,一个球囊阻断血流,另一个球囊腔注入乙醇,必要时多次部署球囊和多支静脉。
临床怎么用
- 对于结构性心脏病消融难治性室速,可考虑多球囊多静脉冠状静脉乙醇消融作为基质消融策略。
- 术中可通过心内超声和三维标测整合消融区域,指导消融。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ablation of ventricular tachycardia (VT) in the setting of structural heart disease often requires extensive substrate elimination that is not always achievable by endocardial radiofrequency ablation. Epicardial ablation is not always feasible. Case reports suggest that venous ethanol ablation (VEA) through a multiballoon, multivein approach can lead to effective substrate ablation, but large data sets are lacking. METHODS: VEA was performed in 44 consecutive patients with ablation-refractory VT (ischemic, n=21; sarcoid, n=3; Chagas, n=2; idiopathic, n=18). Targeted veins were selected by mapping coronary veins on the epicardial aspect of endocardial scar (identified by bipolar voltage <1.5 mV), using venography and signal recording with a 2F octapolar catheter or by guidewire unipolar signals. Epicardial mapping was performed in 15 patients. Vein segments in the epicardial aspect of VT substrates were treated with double-balloon VEA by blocking flow with 1 balloon while injecting ethanol through the lumen of the second balloon, forcing (and restricting) ethanol between balloons. Multiple balloon deployments and multiple veins were used as needed. In 22 patients, late gadolinium enhancement cardiac magnetic resonance imaged the VEA scar and its evolution. RESULTS: Median ethanol delivered was 8.75 (interquartile range, 4.5-13) mL. Injected veins included interventricular vein (6), diagonal (5), septal (12), lateral (16), posterolateral (7), and middle cardiac vein (8), covering the entire range of left ventricular locations. Multiple veins were targeted in 14 patients. Ablated areas were visualized intraprocedurally as increased echogenicity on intracardiac echocardiography and incorporated into 3-dimensional maps. After VEA, vein and epicardial ablation maps showed elimination of abnormal electrograms of the VT substrate. Intracardiac echocardiography demonstrated increased intramural echogenicity at the targeted region of the 3-dimensional maps. At 1 year of follow-up, median of 314 (interquartile range, 198-453) days of follow-up, VT recurrence occurred in 7 patients, for a success of 84.1%. CONCLUSIONS: Multiballoon, multivein intramural ablation by VEA can provide effective substrate ablation in patients with ablation-refractory VT in the setting of structural heart disease over a broad range of left ventricular locations.
引用
- Valderrábano M, Fuentes Rojas SC, Lador A, et al. Substrate Ablation by Multivein, Multiballoon Coronary Venous Ethanol for Refractory Ventricular Tachycardia in Structural Heart Disease. Circulation. 2022. PMID: 36321460. doi:10.1161/CIRCULATIONAHA.122.060882
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。